TELA Bio (TELA) Gross Margin Growth (5y) (2023 - 2026)
TELA Bio (TELA) Gross Margin Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.08 Bn | 175.79 Bn | 6.27 Bn |
| 2 | Stryker | 128.71 Bn | 125.83 Bn | 3.81 Bn |
| 3 | Medtronic | 108.79 Bn | 99.57 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.41 Bn | 66.96 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 7 | Dexcom | 28.34 Bn | 27.22 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.87 Bn | 26.29 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn |
| 10 | TELA Bio | 35.02 Mn | -4.52 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 673.00 |
| Dec 31, 2025 | 129.00 |
| Sep 30, 2025 | 565.00 |
| Jun 30, 2025 | 1,038.00 |
| Mar 31, 2025 | 851.00 |
| Dec 31, 2024 | 266.00 |
| Sep 30, 2024 | 228.00 |
| Jun 30, 2024 | 1,108.00 |
| Mar 31, 2024 | 1,389.00 |
| Dec 31, 2023 | 2,603.00 |
| Sep 30, 2023 | 722.00 |